Publication date: Oct 24, 2019
Imagine the profits in quality of life that can be made by treating inherited diseases early in life, maybe even before birth! Immense cost-savings can also be made by treating diseases promptly. Hence, prenatal stem cell therapy holds great promise for developing new and early stage treatment strategies for several diseases. Successful prenatal stem cell therapy would represent a major step forward in the management of patients with hematological, metabolic, or immunological disorders. However, treatment before birth has several limitations, including ethical issues. In this review, we summarize the past, the present, and the future of prenatal stem cell therapy, which includes an overview of different stem cell types, preclinical studies, and clinical attempts treating various diseases. We also discuss the current challenges and future strategies for prenatal stem cell therapy and also new approaches, which may lead to advancement in the management of patients with severe incurable diseases. Stem Cells Translational Medicine 2019.
- Genomics & Precision Medicine – Prof. Kathryn North
- Moving Beyond ‘Therapy’ and ‘Enhancement’ in the Ethics of Gene Editing.
- Panel: A Look Into the Crystal Ball – What Does the Future Hold for Gene Editing?
- Moving Forward with Biomarkers in Precision Medicine – 2nd Int Congress on Precision Nedicine, Munich, Alain van Gool
- Is the microbiome about to change medicine for good?
- Can Precision Medicine Be a Win-Win for All Stakeholders?